The startup has partnered with Eli Lilly and enjoys the backing of some of Silicon Valley's most influential VCs.

Accelerated drug discovery and development platform Converge Bio Inc. today announced it has raised $25 million in ...

AI and machine learning are revolutionizing drug discovery, development, and lifecycle management, addressing industry ...

Teva Pharmaceuticals TEVA announced a funding agreement with Royalty Pharma plc RPRX, under which the latter will provide up ...

Lilly and NVIDIA launch AI co-innovation lab to tackle drug discovery challenges.NVIDIA collaborates with Thermo Fisher to ...

SAN FRANCISCO, Jan 13 () - AstraZeneca has agreed to buy Boston-based Modella AI, the companies said on Tuesday, as the drug ...

Early-stage regulatory strategy is becoming a powerful driver of speed, risk reduction, and commercial value in drug ...

Collaboration combines Nuclera’s eProtein Discovery System, which accelerates protein expression, purification and optimization, with Cytiva’s Biacore SPR system, which characterizes molecular ...

ATLANTA and MISSISSAUGA, ON, May 28, 2025 /PRNewswire/ -- Radyus Research, a U.S.-based drug development organization, and Eurofins CDMO Alphora, a Canadian contract development and manufacturing ...

The MarketWatch News Department was not involved in the creation of this content. -- Collaboration combines Nuclera's eProtein Discovery System, which accelerates protein expression, purification and ...

Cambridge, UK and Marlborough, MA, 28 May 2025: Nuclera, the biotechnology company accelerating protein expression and optimization through its benchtop eProtein Discovery™ System, has announced a ...

Nuclera, the biotechnology company accelerating protein expression and optimization through its benchtop eProtein Discovery ™ System, has announced a collaboration with Cytiva, a global life sciences ...